Business Description
e-Therapeutics PLC
ISIN : GB00B2823H99
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 276.06 | |||||
Equity-to-Asset | 0.96 | |||||
Debt-to-EBITDA | -0.01 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 16.74 | |||||
Beneish M-Score | -2 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -20.6 | |||||
3-Year EBITDA Growth Rate | -19.3 | |||||
3-Year EPS without NRI Growth Rate | -18.6 | |||||
3-Year FCF Growth Rate | -23.3 | |||||
3-Year Book Growth Rate | 49.7 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 34.6 | |||||
9-Day RSI | 38.13 | |||||
14-Day RSI | 38.81 | |||||
12-1 Month Momentum % | -8.33 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 22.2 | |||||
Quick Ratio | 22.2 | |||||
Cash Ratio | 19.47 | |||||
Days Sales Outstanding | 263.01 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -29.3 | |||||
Shareholder Yield % | -24.82 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -3721.77 | |||||
Net Margin % | -2957.65 | |||||
FCF Margin % | -3063.08 | |||||
ROE % | -35.52 | |||||
ROA % | -33.9 | |||||
ROIC % | -394.21 | |||||
3-Year ROIIC % | -394.88 | |||||
ROC (Joel Greenblatt) % | -548.47 | |||||
ROCE % | -41.87 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 90 | |||||
PB Ratio | 1.91 | |||||
Price-to-Tangible-Book | 1.82 | |||||
EV-to-EBIT | -2.35 | |||||
EV-to-EBITDA | -2.45 | |||||
EV-to-Revenue | 81.87 | |||||
EV-to-FCF | -2.69 | |||||
Price-to-Net-Current-Asset-Value | 1.82 | |||||
Price-to-Net-Cash | 2.28 | |||||
Earnings Yield (Greenblatt) % | -42.55 | |||||
FCF Yield % | -19.66 |